Research Article

A GP130-Targeting Small Molecule, LMT-28, Reduces LPS-Induced Bone Resorption around Implants in Diabetic Models by Inhibiting IL-6/GP130/JAK2/STAT3 Signaling

Figure 7

(a) The weight of SD rats after feeding for 0, 1, 2, 3, and 4 weeks and intraperitoneal injection of 1% STZ solution for 2 weeks. (b) The random blood glucose values of SD rats before intraperitoneal injection of 1% STZ solution and on days 3, 7, and 14 after injection (, ).
(a)
(b)